Priscilla TurelliView profile
Lecturer
Priscilla Turelli is a Lecturer at EPFL's EDMS (Doctoral School of Life Sciences) and a Senior Scientist in the Federal School of Life Sciences. Her primary affiliation is with the Laboratory of Virology and Structural Immunology under the SV-IN unit, and she also collaborates with the Antanasijevic Group. She holds positions in both research and teaching roles, including faculty representation for P3-related scientific activities. Education: PhD in Cellular Biology (1997) - Université de la Méditerranée Master in Cellular Biology (1992) - Université de la Méditerranée Scientific Baccalaureate (1987) - France Research Focus: Her work spans virology, immunology, and epigenetics with a focus on: - KRAB zinc finger proteins' role in cancer and gene regulation - SARS-CoV-2 antibody development and viral mechanisms - Transposable elements' impact on human development and disease Key Research Trends in Publications: Recent work emphasizes structural virology (e.g., ACE2/SARS-CoV-2 interactions), epigenetic control via KRAB-ZFPs, and translational research in antiviral therapeutics. Her lab pioneered the discovery of KRAB-ZFPs' dual role in tumor suppression and immune defense mechanisms. Awards: 2023: Innosuisse Business Concept Training 2004: Bristol-Myers Squibb AIDS Award 1997-1999: Human Frontier Science Program Fellowship Grants & Teams: Leads interdisciplinary projects at EPFL's SV-IN lab and collaborates with industry partners (e.g., Innosuisse). Current projects include: - Development of broad-spectrum SARS-CoV-2 antibodies - KRAB-ZFP-driven cancer immunotherapies - Machine learning applications in protein design Labs/Teams: Core member of the Antanasijevic Lab (UPANTANASIJEVIC unit), coordinating multidisciplinary teams in structural immunology and viral pathogenesis.









